1Wright DR,Thornton C,Hasan K,et al. The effect of remifentanil on the middle latency auditory evoked response and haemodynamike measurements with and without the stimulus of orotracheal intubation. Eur JAnaesthesiol,2004,21:509-516.
3Bouattour L, Ben Amar H,Bouali Y.Maternal and neonatal effects of remifentanil for general anaesthesia for caesarean delivery .Ann Fr Anaesth Reanim,2007,26(4):299-304.
4Chanavaz C,Tirel O,Wodey E,et al.Haemodynamic effects of in children with and without intravenous atropine. Anechocardiographic study.British Journal of anaesthesia ,2005,94(1):74-79.
10Ganne O ,Abisseror M ,Menault P, et al.low-dose ketamine failed to spare morphine after a remifentanil-based anaesthesia for ear ,nose and throat surgery. Eur J Aanaesthesiol,2005,22(6):426-430.
7Rosow CE. An overview of remifentanil. Anesth Analg, 1999, 89: S1- S3.
8Minto CF, Schnider TW, Egan TD, et al. Influnence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: Ⅰ. Model development. Anesthesiology, 1997, 86: 10-23.
9Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology, 1993,79 : 893-903.
10Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999, 89 : S7-S14.
